ZA935276B - 3-(hydroxybenzylidenyl)-indolin-2-ones processes for their preparation and pharmaceutical compositions containing them - Google Patents
3-(hydroxybenzylidenyl)-indolin-2-ones processes for their preparation and pharmaceutical compositions containing themInfo
- Publication number
- ZA935276B ZA935276B ZA935276A ZA935276A ZA935276B ZA 935276 B ZA935276 B ZA 935276B ZA 935276 A ZA935276 A ZA 935276A ZA 935276 A ZA935276 A ZA 935276A ZA 935276 B ZA935276 B ZA 935276B
- Authority
- ZA
- South Africa
- Prior art keywords
- hydroxybenzylidenyl
- indolin
- preparation
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9208951A FR2694004B1 (fr) | 1992-07-21 | 1992-07-21 | Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent. |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA935276B true ZA935276B (en) | 1994-04-18 |
Family
ID=9432072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA935276A ZA935276B (en) | 1992-07-21 | 1993-07-21 | 3-(hydroxybenzylidenyl)-indolin-2-ones processes for their preparation and pharmaceutical compositions containing them |
Country Status (12)
Country | Link |
---|---|
US (1) | US5382593A (xx) |
EP (1) | EP0580502B1 (xx) |
JP (1) | JPH07108900B2 (xx) |
AT (1) | ATE170510T1 (xx) |
AU (1) | AU663200B2 (xx) |
CA (1) | CA2100944A1 (xx) |
DE (1) | DE69320734T2 (xx) |
DK (1) | DK0580502T3 (xx) |
ES (1) | ES2123039T3 (xx) |
FR (1) | FR2694004B1 (xx) |
NZ (1) | NZ248199A (xx) |
ZA (1) | ZA935276B (xx) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5880141A (en) * | 1995-06-07 | 1999-03-09 | Sugen, Inc. | Benzylidene-Z-indoline compounds for the treatment of disease |
US6147106A (en) * | 1997-08-20 | 2000-11-14 | Sugen, Inc. | Indolinone combinatorial libraries and related products and methods for the treatment of disease |
US6906093B2 (en) | 1995-06-07 | 2005-06-14 | Sugen, Inc. | Indolinone combinatorial libraries and related products and methods for the treatment of disease |
CA2179940A1 (en) * | 1995-07-18 | 1997-01-19 | Kazumi Ogata | Antiallergic composition comprising a phosphoric diester compound |
DE69722858T2 (de) * | 1996-01-17 | 2004-05-13 | Taiho Pharmaceutical Co. Ltd. | Intimale verdickungsinhibitoren |
CA2264220A1 (en) * | 1996-08-23 | 1998-02-26 | Sugen, Inc. | Indolinone combinatorial libraries and related products and methods for the treatment of disease |
US20040067531A1 (en) * | 1997-08-20 | 2004-04-08 | Sugen, Inc. | Methods of modulating protein tyrosine kinase function with substituted indolinone compounds |
US6531502B1 (en) * | 1998-01-21 | 2003-03-11 | Sugen, Inc. | 3-Methylidenyl-2-indolinone modulators of protein kinase |
US6569868B2 (en) | 1998-04-16 | 2003-05-27 | Sugen, Inc. | 2-indolinone derivatives as modulators of protein kinase activity |
AU5468499A (en) * | 1998-08-04 | 2000-02-28 | Sugen, Inc. | 3-methylidenyl-2-indolinone modulators of protein kinase |
EP1117397A1 (en) * | 1998-08-31 | 2001-07-25 | Sugen, Inc. | Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
US6680335B2 (en) | 1998-09-28 | 2004-01-20 | Sugen, Inc. | Methods of modulating protein tyrosine kinase function with substituted indolinone compounds |
AU760039B2 (en) | 1998-12-17 | 2003-05-08 | F. Hoffmann-La Roche Ag | 4-aryloxindoles as inhibitors of JNK protein kinases |
CN1158283C (zh) | 1998-12-17 | 2004-07-21 | 霍夫曼-拉罗奇有限公司 | 作为蛋白激酶抑制剂的4-和5-吡嗪基羟吲哚 |
TR200101860T2 (tr) | 1998-12-17 | 2001-12-21 | F.Hoffmann-La Roche Ag | Sikline bağlı kinaz inhibitörleri olarak 4-alkenil (ve alkinil) oksidoller |
US6153634A (en) | 1998-12-17 | 2000-11-28 | Hoffmann-La Roche Inc. | 4,5-azolo-oxindoles |
US6313310B1 (en) | 1999-12-15 | 2001-11-06 | Hoffmann-La Roche Inc. | 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
NZ520640A (en) * | 2000-02-15 | 2005-04-29 | Upjohn Co | Pyrrole substituted 2-indolinone protein kinase inhibitors |
TWI270545B (en) | 2000-05-24 | 2007-01-11 | Sugen Inc | Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
CA2410509A1 (en) * | 2000-06-02 | 2001-12-13 | Sugen, Inc. | Indolinone derivatives as protein kinase/phosphatase inhibitors |
US6504034B2 (en) | 2001-01-23 | 2003-01-07 | Hoffmann-La Roche Inc. | Naphthostyrils |
AR042586A1 (es) * | 2001-02-15 | 2005-06-29 | Sugen Inc | 3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa |
US7186745B2 (en) * | 2001-03-06 | 2007-03-06 | Astrazeneca Ab | Indolone derivatives having vascular damaging activity |
YU90503A (sh) * | 2001-05-14 | 2006-03-03 | Bristol-Myers Squibb Pharma Company | Supstituisani pirazinoni, piridini i pirimidini kao faktor oslobađanja kortikotropina |
AU2002303892A1 (en) | 2001-05-30 | 2002-12-09 | Jingrong Cui | 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors |
AR038957A1 (es) * | 2001-08-15 | 2005-02-02 | Pharmacia Corp | Terapia de combinacion para el tratamiento del cancer |
WO2003031438A1 (en) | 2001-10-10 | 2003-04-17 | Sugen, Inc. | 3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors |
DE10348022A1 (de) * | 2003-10-15 | 2005-05-25 | Imtm Gmbh | Neue Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
WO2006105795A1 (en) * | 2005-04-08 | 2006-10-12 | Leo Pharma A/S | Novel indolinone derivatives |
JP6449470B2 (ja) * | 2015-01-28 | 2019-01-09 | 北京韓美薬品有限公司 | N−安息香酸基置換のベンゾピロリン−2−オン誘導体及びその用途 |
CN109912490B (zh) * | 2018-11-30 | 2020-10-16 | 深圳大学 | 一种吲哚类化合物Plancyindole E及其制备方法 |
CN113214134B (zh) * | 2021-04-30 | 2022-08-30 | 南通大学 | 一种季碳氧化吲哚骨架的合成方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6229570A (ja) * | 1985-07-29 | 1987-02-07 | Kanegafuchi Chem Ind Co Ltd | 3,5−ジイソプロピルベンジリデン複素環式化合物 |
JP2539504B2 (ja) * | 1987-03-11 | 1996-10-02 | 鐘淵化学工業株式会社 | ヒドロキシスチレン誘導体 |
DK0429685T3 (da) * | 1989-07-25 | 1997-12-15 | Taiho Pharmaceutical Co Ltd | Oxoindolderivat |
WO1992007830A2 (en) * | 1990-10-29 | 1992-05-14 | Pfizer Inc. | Oxindole peptide antagonists |
US5124347A (en) * | 1991-07-31 | 1992-06-23 | Warner-Lambert Co. | 3-5-ditertiarybutylphenyl-4-hydroxymethylidene derivatives of 1,3-dihydro-2H-indole-2-ones as antiinflammatory agents |
-
1992
- 1992-07-21 FR FR9208951A patent/FR2694004B1/fr not_active Expired - Fee Related
-
1993
- 1993-07-20 AU AU42046/93A patent/AU663200B2/en not_active Ceased
- 1993-07-20 US US08/094,562 patent/US5382593A/en not_active Expired - Fee Related
- 1993-07-20 CA CA002100944A patent/CA2100944A1/fr not_active Abandoned
- 1993-07-20 JP JP5179064A patent/JPH07108900B2/ja not_active Expired - Lifetime
- 1993-07-20 NZ NZ248199A patent/NZ248199A/en unknown
- 1993-07-21 ES ES93401875T patent/ES2123039T3/es not_active Expired - Lifetime
- 1993-07-21 AT AT93401875T patent/ATE170510T1/de not_active IP Right Cessation
- 1993-07-21 DK DK93401875T patent/DK0580502T3/da active
- 1993-07-21 DE DE69320734T patent/DE69320734T2/de not_active Expired - Fee Related
- 1993-07-21 ZA ZA935276A patent/ZA935276B/xx unknown
- 1993-07-21 EP EP93401875A patent/EP0580502B1/fr not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
NZ248199A (en) | 1995-02-24 |
EP0580502A1 (fr) | 1994-01-26 |
DE69320734D1 (de) | 1998-10-08 |
JPH06179652A (ja) | 1994-06-28 |
ATE170510T1 (de) | 1998-09-15 |
US5382593A (en) | 1995-01-17 |
AU663200B2 (en) | 1995-09-28 |
CA2100944A1 (fr) | 1994-01-22 |
ES2123039T3 (es) | 1999-01-01 |
DE69320734T2 (de) | 1999-05-06 |
FR2694004A1 (fr) | 1994-01-28 |
DK0580502T3 (da) | 1999-05-31 |
AU4204693A (en) | 1994-01-27 |
JPH07108900B2 (ja) | 1995-11-22 |
FR2694004B1 (fr) | 1994-08-26 |
EP0580502B1 (fr) | 1998-09-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA935276B (en) | 3-(hydroxybenzylidenyl)-indolin-2-ones processes for their preparation and pharmaceutical compositions containing them | |
GR3018212T3 (en) | Naphtylalkylamines, process for their preparation and pharmaceutical compositions containing them. | |
ZA926328B (en) | Naphthylethylureas and naphthylethylthioureas process for the preparation thereof and pharmaceutical compositions containing them. | |
GR3029406T3 (en) | Pyridothiadiazines, processes for their preparation and pharmaceutical compositions containing them. | |
ZA936658B (en) | Benzopyran compounds process for their preparation and the pharmaceutical compositions which contain them | |
ZA932359B (en) | 3-Aminochroman spiro compounds processes for preparing them and pharmaceutical compositions containing them | |
ZA933455B (en) | Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
ZA935277B (en) | Aminoalkylchromones processes for the preparation thereof and pharmaceutical compositions containing them | |
CA2137889A1 (fr) | Nouveaux analogues de l'eburnane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
ZA933942B (en) | Pyrrolothienopyrazine compounds, processes for the preparation thereof and pharmaceutical compositions containing them | |
GR3021200T3 (en) | (Cyclohexyl)-alken compounds, process for their preparation and pharmaceutical compositions containing them. | |
ZA948515B (en) | Cyclised analogues of fatty acid metabolites,a process for their preparation and pharmaceutical compositions containing them |